Grade Clinical
Notes
**Note 1:** Grade Clinical must not be blank.
**Note 2:** Assign the highest grade from the primary tumor assessed during the clinical time frame.
* Per clarification from the CAP Cancer Committee based on the CAP Protocol, the following histologies must be assigned a G3 (code 3): Serous, clear cell, undifferentiated/de-differentiated carcinomas, carcinosarcomas, and mixed mesodermal tumors (Mullerian/MMMT) are *high risk (high grade)*
**Note 3:** If there are multiple tumors with different grades abstracted as one primary, code the highest grade
**Note 4:** G3 includes anaplastic.
**Note 5:** Code 9 (unknown) when
* Grade from primary site is not documented
* Clinical workup is not done (for example, cancer is an incidental finding during surgery for another condition)
* Grade checked “not applicable” on CAP Protocol (if available) and no other grade information is available
**Note 6:** If there is only one grade available and it cannot be determined if it is clinical or pathological, assume it is a Grade Clinical and code appropriately per Grade Clinical categories for that site, and then code unknown (9) for Grade Pathological, and blank for Grade Post Therapy Clin (yc) and Grade Post Therapy Path (yp).
Default
9
Metadata
SSDI
| Code |
Description |
| 1 |
G1
FIGO Grade 1
G1: Well differentiated |
| 2 |
G2
FIGO Grade 2
G2: Moderately differentiated |
| 3 |
G3
FIGO Grade 3
G3: Poorly differentiated or undifferentiated |
| 9 |
Grade cannot be assessed (GX); Unknown |
